Cinanserin
Cinanserin (INN) is a 5-HT2A and 5-HT2C receptor antagonist which was discovered in the 1960s.[1]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.220.552 |
Chemical and physical data | |
Formula | C20H24N2OS |
Molar mass | 340.482 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
The preparation is effective against an atypical pneumonia (SARS).[2]
See also
References
- Neuman RS, Zebrowska G (December 1992). "Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity". Canadian Journal of Physiology and Pharmacology. 70 (12): 1604–9. doi:10.1139/y92-230. PMID 1301238.
- http://jvi.asm.org/cgi/content/abstract/79/11/7095
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.